PUBLISHER: IMARC | PRODUCT CODE: 1675329
PUBLISHER: IMARC | PRODUCT CODE: 1675329
The global plant genomics market size reached USD 10.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 18.5 Billion by 2033, exhibiting a growth rate (CAGR) of 6.01% during 2025-2033.
Plant genomics refer to numerous genetic manipulation methods that are used to improve plant quality and aim to determine the manner genetic composition of plants affects plant breeding. With numerous advancements in plant genomics, crop protection may be improved by preventing mycotoxin contamination in plants and allowing crops to survive extreme temperatures. The availability of faster growing plants contributes to maintaining food security and ensuring that nutrients are available in the market. Plant genomics also plays an instrumental role in reducing the spread of diseases through the development of genetically modified crops. Molecular diagnostics, molecular markers, genetic engineering, tissue culture, and the development of beneficial microbes are the main areas of genomics that are employed to improve the quality of crops.
The market is majorly driven by the rising prevalence of protein deficiency among individuals, resulting in the augmenting demand for protein-rich plants. The market is experiencing an increase in the demand for fruit, vegetables, and cereals of high quality due to the increasing population. Also, extensive research and development (R&D) activities conducted for developing numerous advanced plant genomics methods are creating a positive outlook for the market. Apart from this, favorable initiatives taken by the government bodies of several countries promoting improved plant and crop growth programs are providing an impetus to the market. Additionally, the widespread loss of vegetative cover is resulting in the implementation of alternative scientific methods to improve vegetation and increase plant productivity. The market is further propelled by the shifting preference toward genomics over automated instruments due to its cost-efficiency and the growing costs of automated instruments. Some of the other factors contributing to the market include the escalating demand for a bio-based economy to improve food security, rapid urbanization, considerable growth in the food and beverage (F&B) industry, the rising trend of veganism and an enhanced focus on sustainable development.
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., BGI Genomics, Eurofins Scientific SE, Floragenex Inc., GENEWIZ Inc. (Azenta Inc.), Illumina Inc., Keygene N.V., LC Sciences, Neogen Corporation, Novogene Co. Ltd., NRGene Technologies Ltd., Oxford Nanopore Technologies plc and Qiagen N.V. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.